Regulation of age-related macular degeneration-like pathology by complement factor H

Christopher B Toomey1, Una Kelly2, Daniel R Saban3

  • 1Department of Ophthalmology, Duke Eye Center, Duke University, Durham, NC 27710; Department of Cell Biology, Duke University, Durham, NC 27710;

Insights

Reduced complement factor H (CFH) levels worsen age-related macular degeneration (AMD) pathology by increasing deposits and complement activation. This study clarifies CFH

Area of Science:

  • Ophthalmology
  • Immunology
  • Genetics

Background:

  • Complement factor H (CFH) is a key genetic risk factor for age-related macular degeneration (AMD).
  • The precise role of CFH in AMD pathogenesis remains incompletely understood.
  • AMD is a leading cause of vision loss in older adults.

Purpose of the Study:

  • To investigate the in vivo role of CFH in the development of AMD-like pathology.
  • To elucidate the mechanisms by which reduced CFH levels contribute to AMD.
  • To explore CFH's potential as a regulator of lipoprotein binding in Bruch's membrane.

Main Methods:

  • Analysis of aged mice with partial (Cf h(+/-)) and complete (Cf h(-/-)) CFH deficiency on a high-fat diet.
  • Assessment of sub-retinal pigmented epithelium (sub-RPE) deposit formation and RPE damage.
  • Investigation of complement activation pathways.
  • Studies using human Bruch's membrane explants to assess CFH's lipoprotein binding activity.

Main Results:

  • Decreased CFH levels led to increased sub-RPE basal laminar deposits in mice fed a high-fat diet.
  • These deposits result from CFH competition for lipoprotein binding sites in Bruch's membrane.
  • RPE damage and vision loss occurred only in partially deficient mice (Cf h(+/-)) due to excess complement activation, unlike complement-deficient mice (Cf h(-/-)).
  • CFH was shown to remove endogenous lipoproteins from human Bruch's membrane explants.

Conclusions:

  • A combination of advanced age, high-fat diet, and reduced CFH induces sub-RPE deposit formation.
  • This process triggers complement activation, leading to RPE damage and impaired visual function.
  • Findings provide a mechanistic understanding of CFH's role in AMD and suggest therapeutic targets.